50% of Americans Cannot Afford the Diet Their Own Government Just Told Them to Eat ...
On April 13, UBS lifted its price recommendation on Amgen Inc. (NASDAQ:AMGN) to $400 from $390. It reiterated a Buy rating on ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results